G01N2015/1024

SOLVENT COMPOUND FOR A PARTICLE COUNTER/IMAGER AND ASSOCIATED METHOD
20190368985 · 2019-12-05 ·

A solvent compound for a particle counter/imager system, the solvent compound includes a liquid solvent miscible with oil to remove oil from the particle counter/imager system and a liquid dispersive surfactant configured to break large water droplets into smaller droplets less than a predetermined size. The liquid dispersive surfactant is miscible with the solvent and is nontoxic and nonflammable.

Method and apparatus for surface nanoparticle measurement
10478868 · 2019-11-19 · ·

Embodiments described herein generally relate to a particle collection apparatus and probe head for the collection of particles on process tool components. In one embodiment, a particle collection apparatus for counting particles present on a processing tool component is disclosed herein. The particle collection apparatus includes a particle collector. The particle collector is configured to scan a processing tool component and collect particles collected from the processing tool component. The particle collector includes a body and a probe head coupled to the body. The probe head has a probe body and a controlled spacing element. The controlled spacing element is coupled to the probe body and is configured to form a uniform manifold between the probe body and the processing tool component.

INFECTION DETECTION AND DIFFERENTIATION SYSTEMS AND METHODS

Embodiments may include an automated method for evaluating an infection status associated with a blood sample obtained from an individual. Methods may include determining, using a first module, a white blood cell concentration associated with the blood sample. In addition, methods may include determining, using a second module, a monocyte volume measure associated with the blood sample. Methods may include evaluating, using a data processing module, the infection status associated with the blood sample. The data processing module may include a processor and a computer readable medium. The computer readable medium may be programmed with a computer application. This computer application, when executed by the processor, may cause the processor to calculate a parameter using a function comprising the white blood cell concentration and the monocyte volume measure. The computer application may also cause the processor to evaluate the infection status associated with the blood sample based on the parameter.

Particle counter system and detecting apparatus

A detecting apparatus includes a detecting carrier and a detecting device. The detecting carrier can be moved into a charging frame or anyone of storing frames of a stock room. The detecting device is installed in the detecting carrier and includes a power module and a detecting module. The detecting module is configured to detect environment information corresponding in position to the detecting carrier. The power module is configured to supply power for operating the detecting apparatus. When the detecting carrier is arranged in the charging frame, the power module is spaced away from the charging frame and is charged without contacting the charging frame.

REDUCING FALSE COUNTS IN CONDENSATION PARTICLE COUNTERS
20190339186 · 2019-11-07 ·

Various embodiments include methods and apparatuses to reduce false-particle counts in a water-based condensation particle counter (CPC). In one embodiment, a cleanroom CPC has three parallel growth tube assemblies. A detector is coupled to an outlet of each of the three parallel growth tube assemblies, and is used to compare the particle concentrations measured from each of the three growth tube assemblies. An algorithm compares the counts from the three detectors and determines when the particles counted are real and when they are false counts. Any real particle event shows up in all three detectors, while false counts will only be detected by one detector. Statistics are used to determine at which particle count levels the measured counts are considered to be real versus false. Other methods and apparatuses are disclosed.

Blood analysis method, control device and blood cell analyzer

The present disclosure provided a blood cell analyzer, a control device and a blood analysis method thereof. In the method, a first reagent is mixed with a sample to obtain a first testing sample, and then a second reagent is mixed with the first testing sample for a further reaction to get a second testing sample for basophil classification and/or HGB measurement. A blood sample may be tested in one reaction cell through time-division multiplexing technology to obtain four groups leukocytes classification result and HGB result by single detection channel. Thus, the structure of the analyzer may be greatly simplified on the premise of guaranteeing the performance of the analyzer, the size and cost of the analyzer may reduce and a performance-price ratio of the analyzer may increase.

Diagnostic chip

A microfluidic diagnostic chip may comprise a main fluid channel comprising a main pump, a secondary fluid channel branching off from the main fluid channel, and a secondary pump within the secondary fluid channel wherein the secondary pump is to pull a particle of analyte of a first size from a fluid passing through the main channel, the fluid comprising particles of analyte of the first size and of a number of larger sizes. A method of analyzing an analyte on a microfluidic chip may comprise pumping, with a main microfluidic pump, a fluid comprising an analyte particle through a main microfluidic channel fluidly coupled to a fluid slot and sorting the analyte particle within the fluid through a secondary microfluidic channel by pulling the analyte particle into the secondary microfluidic channel with a secondary microfluidic pump.

METHOD OF TREATING PATIENTS WITH HEPATORENAL SYNDROME TYPE 1
20190328831 · 2019-10-31 ·

The principles and embodiments of the present disclosure relate to methods for using terlipressin to treat a patient having impaired renal function associated with liver disease. A patient identified as suffering from HRS-1 is tested to determine if the patient meets at least two out of three criteria, wherein the three criteria include a WBC<4 or >12 cells/4; HR>90 bpm; and any one of HCO3<21 mmol/L or PaCO2<32 mmHg or >20 breaths per minute. If the patient meets at least two of the criteria, he or she is administered terlipressin in an amount effective to produce a reduction in serum creatinine of at least 1.0 mg/dL.

PARTICLE COUNTING APPARATUS
20190317007 · 2019-10-17 ·

An outside opening of each aperture of a plurality of counting chambers for performing particle counting based on the electric resistance method is connected to suction pump through a confluent piping. Liquid supplying part supplies an additional liquid to the counting chamber side after completion of counting of counting chamber, so that the liquid level of sample liquid of counting chamber will not descend to aperture or a predetermined liquid level.

Devices for Detecting or Filtering Tumor Cells

Among others, the present invention provides apparatus comprising two micro-devices each fabricated by the method comprising: the first step of depositing a first material onto a substrate; the second step of depositing a second material onto the first material and then patterning the second material with a microelectronic technology or process; and repeating the second step at least once with a material that can be the same as or different from the first or second material. The micro-devices can pierce through the membrane of a circulating tumor cell and can move in different direction.